| (-)-citrinin | decreases expression | ISO | RGD:67377 | 6480464 | Citrinin results in decreased expression of HSD3B1 protein | CTD | PMID:22564900 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:67377 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [FSHB protein results in increased expression of HSD3B1 mRNA] | CTD | PMID:16737795 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:67377 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of HSD3B1 mRNA] | CTD | PMID:19414516 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1615185 | 6480464 | Ethinyl Estradiol results in decreased expression of HSD3B1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of HSD3B1 mRNA | CTD | PMID:12858341 |
| 17beta-estradiol | decreases expression | ISO | RGD:67377 | 6480464 | Estradiol results in decreased expression of HSD3B1 mRNA | CTD | PMID:16311018 |
| 1H-pyrazole | decreases expression | ISO | RGD:1615185 | 6480464 | pyrazole results in decreased expression of HSD3B6 mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:67377 | 6480464 | Gonadotropins, Equine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of HSD3B1 mRNA] | CTD | PMID:19276399 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1615185 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD3B1 mRNA | CTD | PMID:22889882 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:67377 | 6480464 | [Tetrachlorodibenzodioxin co-treated with FSHB protein] results in increased expression of HSD3B6 mRNA | CTD | PMID:11026553 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD3B1 mRNA | CTD | PMID:21998131 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1615185 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD3B1 mRNA | CTD | PMID:21354282 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:67377 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD3B1 mRNA; more ... | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:67377 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD3B1 mRNA | CTD | PMID:19276399 PMID:18637154 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:67377 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD3B1 mRNA | CTD | PMID:18637154 PMID:19276399 |
| 2,4,6-trichlorophenol | decreases expression | EXP | | 6480464 | 2,4,6-trichlorophenol results in decreased expression of HSD3B1 mRNA | CTD | PMID:21296122 |
| 2-methoxyethanol | increases expression | ISO | RGD:67377 | 6480464 | methyl cellosolve results in increased expression of HSD3B6 mRNA | CTD | PMID:21427058 |
| 2-methoxyethanol | decreases expression | ISO | RGD:67377 | 6480464 | methyl cellosolve results in decreased expression of HSD3B1 mRNA | CTD | PMID:21061450 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:1615185 | 6480464 | 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine inhibits the reaction [[NR4A1 co-treated with THRA] results in increased expression of HSD3B1 mRNA]]; more ... | CTD | PMID:21726595 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1615185 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of HSD3B1 mRNA; more ... | CTD | PMID:18648102 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | decreases expression | ISO | RGD:67377 | 6480464 | AICA ribonucleotide results in decreased expression of HSD3B1 mRNA; more ... | CTD | PMID:16020477 |
| 5-azacytidine | affects expression | ISO | RGD:1615185 | 6480464 | Azacitidine affects the expression of HSD3B1 mRNA | CTD | PMID:18033690 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:1615185 | 6480464 | 2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]; more ... | CTD | PMID:21726595 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD3B1 mRNA | CTD | PMID:22079614 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1615185 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 protein; more ... | CTD | PMID:21726595 |
| acetaldehyde | multiple interactions | ISO | RGD:1615185 | 6480464 | [CGA protein results in increased abundance of Acetaldehyde] which results in increased expression of HSD3B1 mRNA | CTD | PMID:22285649 |
| aflatoxin B1 | decreases expression | ISO | RGD:1615185 | 6480464 | Aflatoxin B1 results in decreased expression of HSD3B6 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of HSD3B1 mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of HSD3B1 mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | increases expression | ISO | RGD:67377 | 6480464 | Tretinoin results in increased expression of HSD3B6 mRNA | CTD | PMID:20488242 |
| ammonium chloride | affects expression | ISO | RGD:67377 | 6480464 | Ammonium Chloride affects the expression of HSD3B6 mRNA; more ... | CTD | PMID:16483693 |
| androst-4-ene-3,17-dione | increases chemical synthesis | EXP | | 6480464 | HSD3B1 protein results in increased chemical synthesis of Androstenedione | CTD | PMID:16054388 |
| androst-5-ene-3beta,17beta-diol | affects metabolic processing | EXP | | 6480464 | HSD3B1 protein affects the metabolism of Androstenediol | CTD | PMID:16054388 |
| Aroclor 1254 | multiple interactions | ISO | RGD:67377 | 6480464 | Ascorbic Acid inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD3B1 mRNA]; more ... | CTD | PMID:17280759 |
| Aroclor 1254 | multiple interactions | ISO | RGD:67377 | 6480464 | lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of HSD3B1 protein] | CTD | PMID:19071209 |
| Aroclor 1254 | decreases activity | ISO | RGD:67377 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased activity of HSD3B1 protein | CTD | PMID:19071209 |
| Aroclor 1254 | decreases expression | ISO | RGD:67377 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD3B1 mRNA | CTD | PMID:17280759 |
| atrazine | decreases expression | ISO | RGD:67377 | 6480464 | Atrazine results in decreased expression of HSD3B1 protein | CTD | PMID:20045047 |
| atrazine | increases expression | ISO | RGD:67377 | 6480464 | Atrazine results in increased expression of HSD3B6 mRNA | CTD | PMID:21427058 |
| benzo[a]pyrene | decreases expression | ISO | RGD:67377 | 6480464 | Benzo(a)pyrene results in decreased expression of HSD3B1 mRNA; more ... | CTD | PMID:21737371 |
| benzo[a]pyrene | affects expression | ISO | RGD:1615185 | 6480464 | Benzo(a)pyrene affects the expression of HSD3B1 mRNA | CTD | PMID:22342234 |
| bis(2-ethylhexyl) phthalate | decreases activity | ISO | RGD:1615185 | 6480464 | Diethylhexyl Phthalate results in decreased activity of HSD3B1 protein | CTD | PMID:17009524 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:67377 | 6480464 | [Diethylhexyl Phthalate co-treated with ethylene dimethanesulfonate] results in decreased expression of HSD3B1 mRNA | CTD | PMID:23064086 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:67377 | 6480464 | Diethylhexyl Phthalate results in decreased expression of HSD3B1 mRNA | CTD | PMID:17229994 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1615185 | 6480464 | Diethylhexyl Phthalate results in increased expression of HSD3B1 protein | CTD | PMID:17009524 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1615185 | 6480464 | Diethylhexyl Phthalate results in decreased expression of HSD3B1 protein | CTD | PMID:17009524 |
| bisphenol A | decreases expression | ISO | RGD:1615185 | 6480464 | bisphenol A results in decreased expression of HSD3B1 mRNA | CTD | PMID:20956811 |
| bisphenol A | increases expression | ISO | RGD:67377 | 6480464 | bisphenol A results in increased expression of HSD3B1 mRNA | CTD | PMID:18180321 |
| bisphenol A | increases expression | ISO | RGD:1615185 | 6480464 | bisphenol A results in increased expression of HSD3B1 mRNA | CTD | PMID:12021184 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of HSD3B1 mRNA | CTD | PMID:12080015 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of HSD3B1 mRNA | CTD | PMID:21592394 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of HSD3B1 mRNA | CTD | PMID:21592394 |
| cefaloridine | increases expression | ISO | RGD:67377 | 6480464 | Cephaloridine results in increased expression of HSD3B1 mRNA | CTD | PMID:18500788 |
| choline | multiple interactions | ISO | RGD:1615185 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HSD3B1 mRNA | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1615185 | 6480464 | Ciguatoxins affects the expression of HSD3B1 mRNA | CTD | PMID:18353800 |
| cis-ketoconazole | decreases expression | ISO | RGD:67377 | 6480464 | Ketoconazole results in decreased expression of HSD3B1 mRNA | CTD | PMID:17229994 |
| clofibrate | increases expression | ISO | RGD:1615185 | 6480464 | Clofibrate results in increased expression of HSD3B6 mRNA | CTD | PMID:17585979 |
| DDT | increases expression | EXP | | 6480464 | DDT results in increased expression of HSD3B1 mRNA | CTD | PMID:12858341 |
| dehydroepiandrosterone | affects metabolic processing | EXP | | 6480464 | HSD3B1 protein affects the metabolism of Dehydroepiandrosterone | CTD | PMID:16054388 |
| dehydroepiandrosterone | affects metabolic processing | ISO | RGD:67377 | 6480464 | HSD3B1 protein affects the metabolism of Dehydroepiandrosterone | CTD | PMID:15261307 |
| delta-hexachlorocyclohexane | decreases expression | ISO | RGD:1615185 | 6480464 | delta-hexachlorocyclohexane results in decreased expression of HSD3B1 mRNA | CTD | PMID:10993823 |
| diarsenic trioxide | decreases expression | ISO | RGD:1615185 | 6480464 | arsenic trioxide results in decreased expression of HSD3B6 mRNA | CTD | PMID:18630931 |
| diazoxide | decreases expression | ISO | RGD:1615185 | 6480464 | Isoproterenol results in decreased expression of HSD3B1 mRNA | CTD | PMID:21335049 |
| dibutyl phthalate | decreases expression | ISO | RGD:67377 | 6480464 | Dibutyl Phthalate results in decreased expression of HSD3B1 mRNA | CTD | PMID:21266533 PMID:15141095 |
| dibutyl phthalate | decreases expression | ISO | RGD:67377 | 6480464 | Dibutyl Phthalate results in decreased expression of HSD3B1 mRNA | CTD | PMID:15141095 PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:67377 | 6480464 | Dibutyl Phthalate results in decreased expression of HSD3B1 protein | CTD | PMID:15141095 |
| dichlorine | multiple interactions | ISO | RGD:67377 | 6480464 | [Ozone co-treated with Chlorine] affects the expression of HSD3B1 mRNA | CTD | PMID:18636392 |
| dichlorine | decreases expression | ISO | RGD:67377 | 6480464 | Chlorine results in decreased expression of HSD3B1 mRNA | CTD | PMID:18636392 |
| diethylstilbestrol | decreases expression | ISO | RGD:67377 | 6480464 | Diethylstilbestrol results in decreased expression of HSD3B1 mRNA | CTD | PMID:17229994 |
| diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of HSD3B1 mRNA | CTD | PMID:12858341 |
| endosulfan | decreases activity | ISO | RGD:67377 | 6480464 | Endosulfan results in decreased activity of HSD3B1 protein | CTD | PMID:11225895 |
| flutamide | increases expression | ISO | RGD:67377 | 6480464 | Flutamide results in increased expression of HSD3B1 mRNA | CTD | PMID:17229994 more ... |
| flutamide | increases expression | ISO | RGD:67377 | 6480464 | Flutamide results in increased expression of HSD3B1 mRNA | CTD | PMID:14967917 more ... |
| flutamide | increases expression | ISO | RGD:67377 | 6480464 | Flutamide results in increased expression of HSD3B1 mRNA | CTD | PMID:21525395 more ... |
| flutamide | increases expression | ISO | RGD:67377 | 6480464 | Flutamide results in increased expression of HSD3B1 mRNA | CTD | PMID:17229994 more ... |
| folic acid | multiple interactions | ISO | RGD:1615185 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HSD3B1 mRNA | CTD | PMID:20938992 |
| gamma-hexachlorocyclohexane | decreases activity | ISO | RGD:67377 | 6480464 | Lindane results in decreased activity of HSD3B1 protein | CTD | PMID:11404799 |
| glutathione | multiple interactions | ISO | RGD:67377 | 6480464 | Glutathione inhibits the reaction [sodium arsenite results in decreased activity of HSD3B1 protein] | CTD | PMID:20580664 |
| Goe 6976 | multiple interactions | EXP | | 6480464 | CRH protein inhibits the reaction [Go 6976 results in increased expression of HSD3B1 mRNA] | CTD | PMID:17170093 |
| Goe 6976 | increases expression | EXP | | 6480464 | Go 6976 results in increased expression of HSD3B1 mRNA | CTD | PMID:17170093 |
| hydroquinone O-beta-D-glucopyranoside | decreases expression | EXP | | 6480464 | Arbutin results in decreased expression of HSD3B1 mRNA | CTD | PMID:17103032 |
| isoprenaline | decreases expression | ISO | RGD:1615185 | 6480464 | Isoproterenol results in decreased expression of HSD3B1 mRNA | CTD | PMID:21335049 |
| isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of HSD3B1 mRNA | CTD | PMID:20436886 |
| L-ascorbic acid | multiple interactions | ISO | RGD:67377 | 6480464 | Ascorbic Acid inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD3B1 mRNA] | CTD | PMID:17280759 |
| L-ascorbic acid | increases expression | EXP | | 6480464 | Ascorbic Acid results in increased expression of HSD3B1 mRNA | CTD | PMID:17901237 |
| L-methionine | multiple interactions | ISO | RGD:1615185 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HSD3B1 mRNA | CTD | PMID:20938992 |
| lycopene | multiple interactions | ISO | RGD:67377 | 6480464 | lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of HSD3B1 protein] | CTD | PMID:19071209 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of HSD3B1 mRNA | CTD | PMID:20044591 |
| methotrexate | affects expression | ISO | RGD:1615185 | 6480464 | Methotrexate affects the expression of HSD3B1 mRNA | CTD | PMID:18502557 |
| methoxychlor | increases expression | EXP | | 6480464 | Methoxychlor results in increased expression of HSD3B1 mRNA | CTD | PMID:12858341 |
| methoxychlor | decreases expression | ISO | RGD:1615185 | 6480464 | Methoxychlor results in decreased expression of HSD3B1 mRNA | CTD | PMID:21514315 |
| methoxychlor | multiple interactions | ISO | RGD:67377 | 6480464 | Methoxychlor metabolite inhibits the reaction [FSHB protein results in increased expression of HSD3B1 mRNA] | CTD | PMID:16737795 |
| ozone | multiple interactions | ISO | RGD:67377 | 6480464 | [Ozone co-treated with Chlorine] affects the expression of HSD3B1 mRNA | CTD | PMID:18636392 |
| paracetamol | affects expression | ISO | RGD:1615185 | 6480464 | Acetaminophen affects the expression of HSD3B6 mRNA | CTD | PMID:17562736 |
| pentachlorophenol | decreases expression | EXP | | 6480464 | Pentachlorophenol results in decreased expression of HSD3B1 mRNA | CTD | PMID:21296122 |
| perfluorooctanoic acid | affects expression | ISO | RGD:1615185 | 6480464 | perfluorooctanoic acid affects the expression of HSD3B1 mRNA | CTD | PMID:21712084 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1615185 | 6480464 | PPARA gene mutant form inhibits the reaction [perfluorooctanoic acid results in decreased expression of HSD3B1 protein] | CTD | PMID:22414604 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1615185 | 6480464 | perfluorooctanoic acid results in decreased expression of HSD3B1 protein | CTD | PMID:22414604 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1615185 | 6480464 | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of HSD3B1 protein] | CTD | PMID:20118188 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1615185 | 6480464 | perfluorooctanoic acid results in increased expression of HSD3B1 protein | CTD | PMID:20118188 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1615185 | 6480464 | PPARA affects the reaction [perfluorooctanoic acid affects the expression of HSD3B1 mRNA] | CTD | PMID:21712084 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1615185 | 6480464 | perfluorooctanoic acid results in decreased expression of HSD3B1 mRNA | CTD | PMID:17681415 |
| permethrin | decreases expression | ISO | RGD:1615185 | 6480464 | Permethrin analog results in decreased expression of HSD3B1 mRNA | CTD | PMID:21745691 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of HSD3B1 mRNA | CTD | PMID:19159669 |
| pirinixic acid | multiple interactions | ISO | RGD:1615185 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HSD3B1 mRNA | CTD | PMID:19710929 |
| pregnenolone | affects metabolic processing | EXP | | 6480464 | HSD3B1 protein affects the metabolism of Pregnenolone | CTD | PMID:16054388 |
| progesterone | increases chemical synthesis | EXP | | 6480464 | HSD3B1 protein results in increased chemical synthesis of Progesterone | CTD | PMID:16054388 |
| progesterone | affects metabolic processing | ISO | RGD:67377 | 6480464 | HSD3B1 protein affects the metabolism of Progesterone | CTD | PMID:15261307 |
| rosiglitazone | decreases expression | ISO | RGD:67377 | 6480464 | rosiglitazone results in decreased expression of HSD3B1 mRNA; more ... | CTD | PMID:21515302 |
| sulpiride | increases expression | ISO | RGD:67377 | 6480464 | Sulpiride results in increased expression of HSD3B6 mRNA | CTD | PMID:21427058 |
| testosterone | increases chemical synthesis | EXP | | 6480464 | HSD3B1 protein results in increased chemical synthesis of Testosterone | CTD | PMID:16054388 |
| testosterone | increases expression | ISO | RGD:67377 | 6480464 | Testosterone results in increased expression of HSD3B1 mRNA | CTD | PMID:17229994 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of HSD3B1 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:67377 | 6480464 | Testosterone results in decreased expression of HSD3B1 mRNA | CTD | PMID:17229994 |
| testosterone | affects chemical synthesis | ISO | RGD:1615185 | 6480464 | HSD3B1 protein affects the chemical synthesis of Testosterone | CTD | PMID:15932923 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of HSD3B1 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | decreases expression | ISO | RGD:67377 | 6480464 | Carbon Tetrachloride results in decreased expression of HSD3B1 mRNA | CTD | PMID:16239168 |
| tetracycline | increases expression | ISO | RGD:1615185 | 6480464 | Tetracycline results in increased expression of HSD3B6 mRNA | CTD | PMID:16917069 |
| toluene | decreases expression | ISO | RGD:67377 | 6480464 | Toluene results in decreased expression of HSD3B1 protein; more ... | CTD | PMID:19110042 |
| triclosan | decreases activity | ISO | RGD:67377 | 6480464 | Triclosan results in decreased activity of HSD3B6 protein | CTD | PMID:19118620 |
| triclosan | decreases expression | ISO | RGD:67377 | 6480464 | Triclosan results in decreased expression of HSD3B6 mRNA | CTD | PMID:19118620 |
| troglitazone | decreases expression | ISO | RGD:67377 | 6480464 | troglitazone results in decreased expression of HSD3B1 mRNA; more ... | CTD | PMID:21515302 |
| valproic acid | affects expression | ISO | RGD:1615185 | 6480464 | Valproic Acid affects the expression of HSD3B1 mRNA | CTD | PMID:17292431 |